In a finding sure to be embraced by proponents of e-cigarettes, researchers at Duke University Medical Center say that smokers may respond better to cessation products that mimic the act of smoking.

UPI reported March 11 that researcher Jed Rose, director of the Duke Center for Nicotine and Smoking Cessation Research, said that cessation products might be more successful if they deliver nicotine to the lungs like cigarettes.

Rose and colleagues at Duke are working on a nicotine-vapor delivery system that could prove superior in reaching the lungs than metered-dose sprays, dry-powder inhalers or nebulizers. “We wanted to replicate the experience of smoking without incurring the dangers associated with cigarettes, and we wanted to do so more effectively than the nicotine replacement therapies currently on the market,” said Rose.